Revenue: The sum of all revenue fields included for a company's operating activities.
Ernexa Therapeutics Inc. (ERNA) had Revenue of $0.58M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.58M |
$-44.55M |
|
$0.10M |
|
$0.49M |
|
$16.26M |
|
$-15.67M |
|
$-28.84M |
|
$-44.51M |
|
$-44.51M |
|
$-44.54M |
|
$-44.54M |
|
$-44.54M |
|
$-44.54M |
|
$-15.67M |
|
$-8.78M |
|
13.65M |
|
13.65M |
|
$-3.26 |
|
$-3.26 |
|
| Balance Sheet Financials | |
$2.35M |
|
$0.09M |
|
$2.92M |
|
$5.27M |
|
$2.94M |
|
-- |
|
$0.63M |
|
$3.57M |
|
$1.70M |
|
$-0.34M |
|
$1.70M |
|
51.39M |
|
| Cash Flow Statement Financials | |
$-15.84M |
|
$-0.36M |
|
$6.26M |
|
$11.67M |
|
$1.73M |
|
$-9.94M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
83.51% |
|
-2693.13% |
|
-2693.13% |
|
-1508.08% |
|
-7647.59% |
|
-7655.50% |
|
$-16.20M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
1.33 |
|
274.06 |
|
-2619.92% |
|
12985.13% |
|
-845.30% |
|
-2618.40% |
|
$0.03 |
|
$-1.19 |
|
$-1.16 |
|